Medication info
Paramacet Tablet

Paramacet Tablet

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›37.5mg / 1 tabletAcetaminophen›325mg / 1 tablet
Manufacturer / importer
Dong-A ST Co., Ltd.
Appearance
Pale yellow oblong film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200805821 · Notified 2008.05.26 · Insurance code 642505230

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Older adults Administer the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to older adults aged 75 years and over, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, an additional dose of this drug is not needed after dialysis to maintain analgesia. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Subsequent doses should be given at intervals of at least 6 hours, and the dose should not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment should be continued.

Ingredients

Manufacturer
Dong-A ST Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate pain
  • severe pain
View approved original text

This medication is used to relieve acute and chronic pain that ranges from moderate to severe.

How to take

Adult dose

Older adults Administer the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to older adults aged 75 years and over, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, an additional dose of this drug is not needed after dialysis to maintain analgesia. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Subsequent doses should be given at intervals of at least 6 hours, and the dose should not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment should be continued.

Precautions

This medicine should be used with caution in individuals who regularly consume more than three alcoholic beverages a day; they must consult their doctor or pharmacist before use. Combining with alcohol can cause liver damage. If any skin rash or hypersensitivity occurs while taking this medication, discontinue use immediately and seek medical attention, as severe skin reactions may occur, though rarely. The tramadol component in this medication may cause seizures, so patients with a history of seizures or high seizure risk must be particularly careful. Also, there is an increased seizure risk when combined with certain antidepressants or opioid analgesics. Patients with acute and severe bronchial asthma may experience difficulty breathing while taking this medication; thus, it must be used under medical supervision. Taking this medication in combination with central nervous system depressants can cause severe drowsiness, respiratory depression, and coma, so caution is necessary when combining. Patients with increased intracranial pressure or head injuries should be careful, as respiratory depression may worsen their symptoms. This medication can cause psychological and physical dependence, necessitating close monitoring for dependency when used over a long period. Patients with liver dysfunction must consult their doctor before use, as the acetaminophen component can burden the liver. Patients with certain genotypes may metabolize this medication rapidly, increasing the risk of respiratory depression; dose adjustments or alternative medications are recommended for such patients. This medication should not be administered to children under 12 years of age and should be avoided in adolescents aged 12 to 18 who have risk factors. This medication may worsen sleep apnea, so symptoms should be continuously monitored, and doses should be reduced or stopped if necessary. Elderly patients or those at risk for hyponatremia should closely observe for symptoms of hyponatremia while taking this medication. Individuals allergic to any of the components of this medication or those suffering from severe respiratory depression, central nervous system drug addiction, or severe liver, kidney, or heart disease should not take it. Sudden discontinuation of this medication can lead to withdrawal symptoms, so doses should be gradually reduced as directed by a physician. This medication may cause drowsiness or dizziness while driving or operating machinery, so caution is warranted. Overdose may pose serious risks including severe respiratory depression, seizures, and liver damage, necessitating immediate medical attention in case of emergency. This medication should be stored safely out of reach of children and should not be shared with others to prevent misuse.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, fatal respiratory depression, hyponatremia, appetite loss, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, irritability, emotional instability, euphoria, decreased libido, sleep disorders, confusion, disorientation, excitement, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, hypersomnia, sensory loss, tremor, paresthesia, attention deficit, syncope, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, cold sweat, urinary disturbance, erectile dysfunction, asthenia, chest pain, emotional abnormalities, chills, chest discomfort, malaise, withdrawal syndrome due to medication, thirst, irritability, sensation of heat, weight loss, increased serum creatinine, anaphylactic reaction, Stevens-Johnson syndrome, toxic epidermal necrolysis, impact on emotional instability, delirium, suicidal thoughts, hypertonia, movement disorders, serotonin syndrome, speech impairment, mydriasis, orthostatic hypotension, hepatitis, gait disturbance, prolonged prothrombin time, thrombocytopenia, agranulocytosis, blood disorders, hypoprothrombinemia, fatigue-glutamic acidosis, high-anion gap metabolic acidosis, fixed rash, asthenia, fever, edema, rigidity, syncope, congestive heart failure, vertigo, stupor, worsening of migraine, involuntary contractions of muscles, dyspnea, asthma, exercise-induced dyspnea, cough, bronchitis, urinary retention, polyuria, abnormal renal function parameters, oliguria, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, drowsiness, insomnia, appetite loss, anxiety, depression, irritability, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, thrombocytopenia, palpitations, worsening hypertension, arrhythmia, aortic stenosis, bleeding, increased cholesterol levels, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal visual field, progression of biliary cancer, foreign body sensation in the eye, progression of liver cancer, liver dysfunction, nausea, dizziness, seizures, stupor, dyspnea, vomiting, dyspepsia, confusion, multiple organ failure, anaphylaxis, intentional overdose, belching, chest discomfort, anxiety, sweating, rigidity, pain, upper respiratory syndrome, lip biting, excitement, hyperactivity, panic attacks, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system response, urticaria, rash, bronchospasm, toxic skin necrosis, opioid-induced hyperalgesia, withdrawal symptoms, acute or chronic adrenal insufficiency, severe abdominal pain, hypotension, extreme fatigue, appetite loss, weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is advisable to maintain storage temperatures between 1 degree and 30 degrees Celsius. This will help preserve the drug's effectiveness and safety for a long time.

Appearance and packaging

Appearance

Pale yellow oblong film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.